Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization

CompletedOBSERVATIONAL
Enrollment

262

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 31, 2019

Conditions
Osteomyelitis
Interventions
DRUG

Antimicrobial

Antimicrobial therapy according to A. baumannii susceptibility profile

Trial Locations (1)

05403010

Instituto de Ortopedia e Traumatologia do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Sao Paulo

OTHER

NCT03559530 - Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization | Biotech Hunter | Biotech Hunter